{
    "name": "vestronidase alfa-vjbk",
    "comment": "Rx",
    "other_names": [
        "Mepsevii"
    ],
    "classes": [
        "Metabolic & Endocrine",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/mepsevii-vestronidase-alfa-vjbk-1000214",
    "pregnancy": {
        "common": [
            "No data are available regarding use in pregnant women",
            "When administered to pregnant rats and rabbits during organogenesis, vestronidase alfa showed no maternal toxicity or adverse developmental outcomes at doses causing maternal serum exposures (AUC) up to 1.6 and 10 times, respectively for rats and rabbits, the exposure at the recommended human dose"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Unknown if present in either human or animal milk; the effects on the breastfed infant, or the effects on milk production"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Anaphylaxis has occurred as early as the first dose; therefore, appropriate medical support should be readily available during IV infusion",
                "Closely observe patient during and for 60 minutes after infusion",
                "Immediately discontinue treatment if anaphylaxis occurs"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Anaphylaxis was reported in the clinical program; reactions occurred during infusion and were observed as early as the first dose; manifestations included respiratory distress, cyanosis, decreased oxygen saturation, and hypotension; administer under supervision of a healthcare professional with experience managing anaphylaxis (see Dosing Considerations and Black Box Warnings)"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Extravasation",
            "percent": "0.5"
        },
        {
            "name": "Diarrhea",
            "percent": "0.4"
        },
        {
            "name": "Rash",
            "percent": "0.4"
        },
        {
            "name": "Anaphylaxis",
            "percent": "0.4"
        },
        {
            "name": "Infusion site swelling",
            "percent": "0.1"
        },
        {
            "name": "Peripheral swelling",
            "percent": "0.1"
        },
        {
            "name": "Pruritus",
            "percent": "0.1"
        }
    ]
}